Table 3 Clinicopathologic features of detected neoplastic lesions (only the first procedure in each group)
Variable | Routine-first group (27 patients/29 lesions) | CAD-first group (53 patients/57 lesions) |
|---|---|---|
Size, mm, n (%) | ||
10 mm | 12 (41.38) | 26 (45.61) |
>10–19 mm | 11 (37.93) | 19 (33.33) |
>19 mm | 6 (20.69) | 12 (21.05) |
Location, n (%) | ||
Ce | 1 (3.45) | 5 (8.77) |
Ut | 1 (3.45) | 4 (7.02) |
Mt | 9 (31.03) | 15 (26.32) |
Lt | 18 (62.07) | 33 (57.89) |
Ae | 0 (0) | 0 (0) |
Morphology, n (%) | ||
Unidentified | 1 (3.45) | 0 (0) |
Protruded | 14 (48.28) | 13 (22.81) |
Flat | 5 (17.24) | 18 (31.58) |
Depressed | 9 (31.03) | 26 (45.61) |
Pathological diagnosis, n (%) | ||
LGIN | 2 (6.90) | 8 (14.04) |
HGIN | 10 (34.48) | 25 (43.86) |
Squamous carcinoma | 17 (58.62) | 23 (40.35) |
Adenocarcinoma | 0 (0) | 1 (1.75) |
